section name header

Basics

Basics

Definition

An infectious disease primarily affecting the skin or GI tract of dogs and cats. It is caused by the aquatic pathogen Pythium insidiosum, an organism in the class Oomycetes.

Pathophysiology

  • The infective form of P. insidiosum is thought to be the motile biflagellate zoospore, which is released into warm water environments and is chemotactically attracted to damaged tissue and animal hair. Animals are likely infected when they enter or ingest water that contains infective zoospores.
  • P. insidiosum is considered a pathogenic rather than opportunistic organism because immune suppression is not a prerequisite for infection.
  • In the GI tract, P. insidiosum infection causes chronic pyogranulomatous disease manifested by severe segmental transmural thickening of one or more areas of the stomach or intestine.
  • In the skin, pythiosis typically results in the development of non-healing wounds and invasive masses that contain ulcerated nodules and draining tracts.

Systems Affected

  • GI and cutaneous forms of the disease are encountered with equal frequency in the dog. In cats, which are infrequently infected, the cutaneous form is more common. With the exception of occasional dissemination to regional lymph nodes, pythiosis usually affects only one body system in each patient.
  • GI pythiosis most often affects the gastric outflow region, proximal small intestine, ileocolic junction, or colon. The surrounding mesentery is often involved. Rarely, the esophagus may be affected.
  • In dogs with GI disease, P. insidiosum-induced local thromboembolic events or vascular invasion may lead to bowel wall ischemia and GI perforation or hemoabdomen.
  • Dogs with cutaneous pythiosis most often are presented for solitary or multiple cutaneous or subcutaneous lesions involving the extremities, tailhead, ventral neck, or perineum.
  • In cats, cutaneous lesions or subcutaneous masses involving retrobulbar, periorbital, or nasopharyngeal regions, the tailhead, or the footpads have been observed. GI lesions are rare in cats.
  • Multisystemic involvement is rare.

Genetics

Although large-breed dogs are most often affected, no genetic predisposition has been documented.

Incidence/Prevalence

  • Dependent on geographic distribution.
  • Affected animals more often are presented for signs of disease in the fall or early winter months.

Geographic Distribution

  • Disease caused by P. insidiosum occurs primarily in tropical and subtropical areas of the world.
  • In the United States, pythiosis occurs most often in states bordering the Gulf of Mexico; however, it has also been documented in Oklahoma, Arkansas, Missouri, Kentucky, Tennessee, North and South Carolina, Virginia, southern Indiana, New Jersey, Arizona, Wisconsin, and California.
  • Outside the United States, pythiosis has been reported in Australia, Brazil, Burma, Colombia, Costa Rica, Indonesia, Japan, New Guinea, and Thailand.

Signalment

Species

Dog and less commonly cat

Breed Predilections

  • Large-breed dogs, especially those used in hunting or field trial work near water.
  • Labrador retrievers are overrepresented.
  • German shepherds may be predisposed to cutaneous pythiosis.

Mean Age and Range

Animals <6 years old are most likely to be infected.

Predominant Sex

Males are affected more often than females, possibly because of increased exposure.

Signs

General Comments

Affected dogs are not usually severely ill until late in the course of disease.

Historical Findings

  • Chronic weight loss and intermittent vomiting are the most common signs.
  • Diarrhea may be evident if the colon or a large segment of the small intestine is affected.
  • Regurgitation is noted with esophageal disease.
  • Cutaneous disease is characterized by non-healing wounds with nodules that ulcerate and drain.

Physical Examination Findings

GI Pythiosis

  • Emaciation is common.
  • An abdominal mass is often palpable.
  • Despite severe weight loss, affected dogs are usually bright and alert.
  • Fever is usually absent.
  • Systemic signs and abdominal pain may occur with intestinal obstruction, infarction, or perforation.

Cutaneous Pythiosis

  • Cutaneous or subcutaneous lesions appear as non-healing wounds; boggy, edematous regions; or poorly defined nodules that become ulcerated.
  • Multiple tracts draining a serosanguineous or purulent exudate often are present.

Causes

P. insidiosum

Risk Factors

  • Environmental exposure to swampy areas, bayous, ponds, or lakes containing infective zoospores.
  • Outdoor activities such as hunting.

Diagnosis

Diagnosis

Differential Diagnosis

GI Pythiosis

  • Intestinal obstruction caused by a foreign body or chronic intussusception.
  • Histoplasmosis.
  • Gastric or intestinal lymphosarcoma.
  • Gastric carcinoma.
  • Other GI neoplasia.
  • Inflammatory bowel disease.
  • Basidiobolomycosis, protothecosis.
  • Histiocytic or idiopathic colitis.

Cutaneous Pythiosis

  • Lagenidiosis (caused by oomycotic pathogens in the genus Lagenidium).
  • Zygomycosis (infections caused by Basidiobolus or Conidiobolus spp.).
  • Other mycotic skin diseases, such as cryptococcosis, coccidioidomycosis, sporotrichosis, eumycotic mycetoma, and phaeohyphomycosis.
  • Nodular bacterial skin diseases, such as actinomycosis, mycobacteriosis, botryomycosis, and brucellosis.
  • Protothecosis or nodular leishmaniasis.
  • Non-infectious pyogranulomatous diseases, such as foreign-body reaction, idiopathic nodular panniculitis, sebaceous nodular adenitis, and canine cutaneous sterile pyogranuloma/granuloma syndrome.
  • Cutaneous neoplasia.
  • Systemic vasculitis and cutaneous embolic disease.

CBC/Biochemistry/Urinalysis

  • Laboratory findings are nonspecific.
  • Eosinophilia, leukocytosis, and anemia of chronic disease may occur.
  • Hyperglobulinemia and/or hypoalbuminemia may be noted in chronically affected dogs.
  • Hypokalemia, hyponatremia, hypochloridemia, and metabolic alkalosis may be noted in dogs with gastric outflow obstruction.
  • Hypercalcemia was reported in a single affected dog.
  • Urinalysis usually normal.

Other Laboratory Tests

Serology-a sensitive and specific ELISA test for anti-Pythium antibody is available at Auburn University College of Veterinary Medicine.

Imaging

  • Abdominal radiography may reveal an obstructive pattern, bowel wall thickening, or abdominal mass.
  • Abdominal ultrasonography may reveal segmental transmural thickening of the stomach, proximal small intestine, or ileocolic junction. Granulomas or enlarged lymph nodes may be evident in the mesentery.

Diagnostic Procedures

  • Biopsy of gastrointestinal or skin lesions demonstrates histologic changes that are suggestive of, but not definitive for, pythiosis.
  • Definitive diagnosis is based on serology or culture; tissue samples should be submitted to an experienced laboratory via overnight shipping at room temperature.
  • A nested PCR assay can be used for the definitive identification of cultured isolates or organisms in tissue samples.

Pathologic Findings

  • Histologically, GI and skin lesions are characterized by pyogranulomatous and eosinophilic inflammation associated with broad (4–6 micron), irregularly branching, infrequently septate hyphae with thick, non-parallel walls.
  • Predominance of eosinophils within the inflammatory reaction helps to differentiate pythiosis, lagenidiosis, and zygomycosis from other mycotic infections.
  • Hyphal organisms are usually not visible on hematoxylin and eosin-stained sections, but are readily visualized with a silver stain.
  • Dogs with GI lesions typically have severe segmental thickening of portions of stomach and/or bowel, often with obstruction of the intestinal lumen.
  • Mesenteric lymphadenopathy is often noted, but the presence of P. insidiosum hyphae within lymph nodes is uncommon.
  • Histologically, GI pythiosis is characterized by eosinophilic and pyogranulomatous inflammation with necrotic foci and discrete granulomas that contain hyphae.

Treatment

Treatment

Appropriate Health Care

The treatment of choice is aggressive surgical excision of all infected tissue. Unfortunately, many animals are not presented to the veterinarian until late in the disease, when complete resection is not possible.

Nursing Care

Supportive care should include fluids, potassium, and nutritional support. Antibiotics may be indicated to treat secondary pyoderma in dogs with cutaneous lesions.

Activity

Limit activity

Diet

Feed a highly digestible, calorie-dense diet

Client Education

  • Treatment is expensive.
  • Prognosis is guarded to poor unless a complete resection is feasible.

Surgical Considerations

  • Attempt wide surgical excision to obtain 5- to 6-cm margins even if medical therapy is contemplated.
  • Amputation is recommended for treatment of extremity lesions.
  • Enlarged mesenteric lymph nodes should be biopsied but often do not contain infective hyphae, thus do not have to be removed.
  • Dogs often improve after obstructive lesions are resected, even if significant disease is still grossly evident.
  • Postoperative medical therapy with itraconazole and terbinafine (see below) for 2–3 months may decrease the chance of recurrence.
  • Reevaluation of ELISA serology 2–3 months after surgery is an excellent prognostic indicator.

Medications

Medications

Drug(s) Of Choice

  • Itraconazole (10 mg/kg PO daily) combined with terbinafine (10 mg/kg PO daily) appears to be most effective. Although controlled studies have not been performed, the efficacy of this combination is probably <10% in dogs with non-resectable or partially resectable lesions.
  • Prednisone (1–2 mg/kg PO daily and then tapered over 2–3 months) added to antifungal drugs may improve clinical outcome.
  • Medical therapy should be continued for a minimum of 6 months.
  • Give itraconazole with food.

Precautions

  • Azole drugs should not be used in animals with severe liver disease.
  • Anorexia, high liver enzymes, and cutaneous vasculitis are the most common adverse affects of itraconazole.

Possible Interactions

Antacids and anticonvulsants may decrease blood levels of itraconazole.

Alternative Drug(s)

Prednisone (1–2 mg/kg PO daily and then tapered over several months) routinely improves clinical signs in the short term. In addition, the author has observed complete long-term resolution of clinical signs in a small number of dogs with GI pythiosis treated with prednisone alone. This is not recommended as a primary treatment for dogs with resectable lesions, but should be considered as palliative therapy in dogs with nonresectable disease.

Follow-Up

Follow-Up

Patient Monitoring

  • ELISA serology can be used to monitor response to therapy; serology should be checked 2–3 months after surgery or every 3 months during medical therapy.
  • Abdominal ultrasonography is useful in reevaluating intestinal lesions.
  • Liver enzymes should be evaluated monthly while patient is on itraconazole.

Prevention/Avoidance

Monitor for signs of recurrence.

Possible Complications

Acute abdomen and death from GI thrombosis and perforation

Expected Course and Prognosis

Prognosis is guarded to poor unless a complete resection is possible.

Miscellaneous

Miscellaneous

Age-Related Factors

Young animals are predisposed.

Zoonotic Potential

Infections in humans are very rare and are from a common environmental source. There is no evidence of direct transmission from animals to humans.

Pregnancy/Fertility/Breeding

Azole antifungals are teratogenic and should not be used in pregnant animals.

Synonyms

  • Phycomycosis
  • Swamp Cancer

Abbreviations

  • ELISA = enzyme-linked immunosorbent assay
  • GI = gastrointestinal
  • PCR = polymerase chain reaction

Suggested Reading

Grooters AM. Pythiosis, Lagenidiosis, and Zygomycosis. In: Sykes JE ed. Canine and Feline Infectious Diseases. St. Louis, MO: Elsevier Saunders, 2014.

Grooters AM, Gee MK. Development of a nested PCR assay for the detection and identification of Pythium insidiosum. J Vet Intern Med 2002, 16:147152.

Grooters AM, Leise BS, Lopez MK, et al. Development and evaluation of an enzyme-linked immunosorbent assay for the serodiagnosis of pythiosis in dogs. J Vet Intern Med 2002, 16:142146.

Author Amy M. Grooters

Consulting Editor Stanley L. Marks

Client Education Handout Available Online